Anonychia-microcephaly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1094OMIM:607214Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Anonychia-microcephaly syndrome is an extremely rare genetic disorder characterized by the combination of anonychia (complete absence of fingernails and toenails) and microcephaly (an abnormally small head circumference, reflecting reduced brain size). This condition is present from birth, with the nail abnormalities and small head size being apparent in the neonatal period. The syndrome primarily affects the integumentary system (nails) and the central nervous system (brain development). Affected individuals may also exhibit intellectual disability of variable severity associated with the microcephaly. The condition has been reported in very few families in the medical literature, making it one of the rarest described genetic syndromes. The original reports described affected siblings born to consanguineous parents, supporting an autosomal recessive pattern of inheritance. The underlying molecular genetic cause has not been definitively established. There is currently no specific or curative treatment for anonychia-microcephaly syndrome. Management is supportive and symptomatic, focusing on developmental support and educational interventions for individuals with intellectual disability. Monitoring of growth parameters, neurological development, and appropriate referrals to specialists such as neurologists and developmental pediatricians are recommended. Genetic counseling is advised for affected families to discuss recurrence risks and family planning options.

Also known as:

Clinical phenotype terms— hover any for plain English:

Aplastic/hypoplastic toenailHP:0010624
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Anonychia-microcephaly syndrome.

View clinical trials →

No actively recruiting trials found for Anonychia-microcephaly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Anonychia-microcephaly syndrome community →

No specialists are currently listed for Anonychia-microcephaly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Anonychia-microcephaly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Anonychia-microcephaly syndromeForum →

No community posts yet. Be the first to share your experience with Anonychia-microcephaly syndrome.

Start the conversation →

Latest news about Anonychia-microcephaly syndrome

No recent news articles for Anonychia-microcephaly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Anonychia-microcephaly syndrome

What is Anonychia-microcephaly syndrome?

Anonychia-microcephaly syndrome is an extremely rare genetic disorder characterized by the combination of anonychia (complete absence of fingernails and toenails) and microcephaly (an abnormally small head circumference, reflecting reduced brain size). This condition is present from birth, with the nail abnormalities and small head size being apparent in the neonatal period. The syndrome primarily affects the integumentary system (nails) and the central nervous system (brain development). Affected individuals may also exhibit intellectual disability of variable severity associated with the mic

How is Anonychia-microcephaly syndrome inherited?

Anonychia-microcephaly syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Anonychia-microcephaly syndrome typically begin?

Typical onset of Anonychia-microcephaly syndrome is neonatal. Age of onset can vary across affected individuals.